SB 774
Provides funding for umbilical cord blood banks and non-fetal human stem cell research
LR Number:
Last Action:
4/18/2006 - Voted Do Pass S Judiciary and Civil & Criminal Jurisprudence Committee
Journal Page:
Calendar Position:
Effective Date:
August 28, 2006

Current Bill Summary

SB 774 - This act requires 25% of the funds received from subsequent participating manufacturers in the Tobacco Master Settlement Agreement that are deposited into the Life Sciences Research Trust Fund, be expended by the Life Sciences Research Board.

The board shall expend 25% of such money to fund the program that awards grants for the establishment of umbilical cord blood banks and for the expansion of existing umbilical cord blood banks. It shall expend 75% of such money to fund life science projects involving the study, use, or therapies involving human stem cells derived from non-embryonic and non-fetal sources.